HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Triller, D. M. Articles by Hamilton, R. A. Search for Related Content PubMed PubMed Citation Articles by Triller, D. M. Articles by Hamilton, R. A. Social Bookmarking                         What's this?

DARREN M. TRILLER, PHARM.D., is Director, Medicare Pharmacy Projects, IPRO, Albany, NY; at the time of writing he was Assistant Professor of Pharmacy Practice, Albany College of Pharmacy (ACP), Albany. ROBERT A. HAMILTON, PHARM.D., is Professor, Department of Pharmacy Practice, ACP.

Address correspondence to Dr. Hamilton at the Department of Pharmacy Practice, Albany College of Pharmacy, 106 New Scotland Avenue, Albany, NY 12208 (hamiltor{at}acp.edu).

Purpose. The effect of pharmaceutical care services for home care patients with heart failure on death and rehospitalization rates was studied. Methods. Eligible patients had to be at least 21 years old and included those with a primary or secondary diagnosis of heart failure who were referred to receive skilled nursing services. Patients were then randomized to receive usual care or pharmaceutical care. Patients assigned to the usual care group received the services typically provided by the visiting nurses association, while patients in the pharmaceutical care group received usual care plus standardized services from a clinical pharmacist. Pharmaceutical care services consisted of an initial comprehensive inhome medication assessment and two follow-up visits. Throughout the three-week intervention period, the clinical pharmacist accessed and reviewed all pertinent physician notes and laboratory test values and interacted with prescribers on behalf of the patients as necessary. Results. A total of 154 patients met all criteria and participated in the study. The pharmacist made 79 specific therapy recommendations, 47 (60%) of which were related directly to drug therapy for heart failure or cardiovascular disease. Overall, 14 therapy recommendations were fully implemented, and 10 heart failure-specific recommendations were fully implemented. Patients for whom the pharmacist had made recommendations that were followed by the prescriber had a reduced rate of the composite primary endpoint, but this difference did not reach statistical significance. Conclusion. A home-based pharmaceutical care model for recently hospitalized patients with heart failure did not significantly improve the combined rate of death or rehospitalization. Index terms: Clinical pharmacists; Health care; Heart failure; Mortality; Pharmaceutical care; Pharmaceutical services

 

CiteULike    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				S. L. Koshman, T. L. Charrois, S. H. Simpson, F. A. McAlister, and R. T. Tsuyuki Pharmacist Care of Patients With Heart Failure: A Systematic Review of Randomized Trials Arch Intern Med, April 14, 2008; 168(7): 687 - 694. [Abstract] [Full Text] [PDF]